Global Nuclear Medicine Market Size, Industry Trends, Growth Prospects Till, 2022 : Acute Market Reports
The
Global Nuclear Medicine Market accounted for $8.8 billion in 2014 and is
expected to grow at a CAGR of 9.6% to reach $20.4 billion by 2022. Nuclear
medicine uses radiation to provide diagnostic information about the functioning
of a person's specific organs, or to treat them. According to World nuclear
association, Over 10,000 hospitals across the world use radioisotopes in
medicine, and about 90% of the procedures are for diagnosis. The most commonly
used radioisotope in diagnosis is technetium-99, accounting for more than 80%
of all nuclear medicine procedures worldwide. Computed X-ray tomography (CT)
scans and nuclear medicine contribute 36% of the total radiation exposure and
75% of the medical exposure to the U.S. population, according to a US National
Council on Radiation Protection & Measurements report.
Get
more insights about the Global Nuclear Medicine Market, 2022 or request for
sample of this report - http://www.acutemarketreports.com/report/nuclear-medicine-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022
Factors
driving the nuclear medicine market include advancements in radiotracers,
increasing number of patients with cancer and cardiovascular ailment,
increasing use of SPECT and PET scan results and alpha radio immunotherapy-based
targeted cancer treatment. However, factors such as stringent regulatory
guidelines, high capital investment, shorter half-life of radiopharmaceuticals
and competition from conventional diagnostic procedures are inhibiting the
growth of nuclear medicine market. Technological advancements in neurological
applications and increasing demand from emerging countries are likely to create
huge opportunities for the market growth.
The
Global nuclear medicine market is segmented on the basis of type, application
and geography. By type, the market is classified into nuclear medicine
diagnostic market and nuclear medicine therapeutic isotopes market. Based on
the application, the nuclear medicine market is categorized into diagnostics
and therapeutics applications. The diagnostic application is further segmented
into SPECT and PET market, where SPECT market comprises cardiology, neurology,
thyroid and other diagnostic applications. The PET market comprises oncology
and other PET applications. The therapeutics application is further segmented
into thyroid, bone metastasis, endocrine tumors and other therapeutic
applications. By geography, it is segmented into North America, Europe, Asia
Pacific and Rest of the World. North America followed by the Europe dominates
the global nuclear medicine market.
Some
of the key players in nuclear medicine market include GE Healthcare (U.K.),
Nordion, Inc. (Canada), Bayer Healthcare (Germany), Cardinal Health, Inc.
(U.S.), Siemens Healthcare (PETNET) (Germany)., IBA Group (Belgium), Lantheus
Medical Imaging, Inc. (U.S.), Eczacibasi-Monrol Nuclear Products (Turkey),
Ashby Gorman Baker Ltd, and Mediso Ltd.
Browse
All Reports of This Category - http://www.acutemarketreports.com/category/chemicals-market
About
Acute Market Reports
Acute
Market Reports is the most sufficient collection of market intelligence
services online. It is your only source that can fulfill all your market
research requirements. We provide online
reports from over 100 best publishers and upgrade our collection regularly to
offer you direct online access to the world’s most comprehensive and recent
database with expert perceptions on worldwide industries, products,
establishments and trends. Our database consists of 200,000+ market research
reports with detailed & minute market research. View more - http://www.acutemarketreports.com
Contact
Us:
Chris
Paul
Office
No 01, 1st Floor,
Aditi
Mall, Baner, Pune,
MH,
411045 India
Phone
(India): +91 7755981103
Toll
Free (US/Canada): +1-855-455-8662
Email: sales@acutemarketreports.com
Comments
Post a Comment